Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunogenetic Profiling of Goeckerman Therapy in the Treatment of Psoriasis Vulgaris

NCT03662685 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT03662685
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03662685 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunogenetic Profiling of Goeckerman Therapy in the Treatment of Psoriasis Vulgaris
Lead sponsor
University of California, San Francisco
Phase
Phase 1
Overall status
Terminated
Start date
August 1, 2018
Completion date
May 31, 2024
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis, psoriasis vulgaris